Cover Image
市場調查報告書

全球胃腸道基質腫瘤市場

Global Market Study on Gastrointestinal Stromal Tumor: Stomach Indications to Account for Largest Revenue Share during 2017-2026

出版商 Persistence Market Research 商品編碼 602286
出版日期 內容資訊 英文 170 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球胃腸道基質腫瘤市場 Global Market Study on Gastrointestinal Stromal Tumor: Stomach Indications to Account for Largest Revenue Share during 2017-2026
出版日期: 2017年12月13日 內容資訊: 英文 170 Pages
簡介

本報告提供全球胃腸道基質腫瘤市場相關調查,彙整市場概要和各市場區隔,各地區趨勢,及加入此市場的主要企業的簡介等資料。

第1章 經濟預測

第2章 摘要整理

第3章 市場概要

  • 簡介
  • 市場規模與預測
  • 市場趨勢
  • 供應鏈
  • 成本結構
  • 價格分析
  • 藥物開發平台評估
  • PESTL分析
  • 經銷商清單
  • 各地區主要加入企業的市場地位

第4章 全球市場分析與預測

  • 各適應症
    • 小腸
    • 其他
  • 各終端用戶
    • 醫院
    • 診療所
    • 特定癌症治療中心
    • 其他
  • 治療類別
    • 標靶藥物療法
    • 化療
    • 放射線治療
    • 手術
    • 其他

第5章 北美市場

第6章 南美市場

第7章 歐洲市場

第8章 日本市場

第9章 APEJ市場

第10章 中東·非洲市場

第11章 企業佔有率分析,競爭環境,企業簡介

  • 企業佔有率分析
  • 競爭環境
  • 企業簡介
    • Novartis AG
    • Sun Pharmaceutical Industries Limited
    • Pfizer Inc.
    • Bayer Aktiengesellschaft
    • NATCO Pharma Limited

第12章 調查方法

第13章 一次·二次來源

第14章 假設和簡稱

第15章 免責聲明

目錄

Persistence Market Research has developed an exclusive and in-depth market analysis and forecast for gastrointestinal stromal tumor (GIST). The report covers the expansion of gastrointestinal stromal tumor market across global, regional and local perimeters. The study has been developed to deliver accurate forecast on market size estimations for the assessment period, 2017-2026. From drug development and epidemiology analysis to market entry barriers and changing regulations in the healthcare industry - a range of causative factors for the growth of the global gastrointestinal stromal tumor market have been studied and applied. The impact of these factors is assessed to create presumptive scenarios on how the global gastrointestinal stromal tumor market will expand in the near future.

Companies partaking in the global gastrointestinal stromal tumor market can avail this report to understand the underlying premise of developments in GIST treatments and devise strategies based on the inferences provided in the report. This report serves as a reliable business document for pharmaceutical companies interested in extending their presence in the global gastrointestinal stromal tumor market in the upcoming years.

Report Synopsis:

Analysis and forecast on the global gastrointestinal stromal tumor market has been provided in terms of market size estimations. The report includes a slew of sections reveal the estimated forecast on market and its key segments. The report provides an overview of the overall healthcare industry, addressing the latest trends and breakthrough happenings, which puts forth a connection between the changing healthcare landscape and the evolving marketplace for treatments on gastrointestinal stromal tumors.

Cost structure breakdown, pricing analysis, technology trends, FDA pipeline snapshot, and analysis on drug distribution network has been provided in the report as well. The report further delivers a detailed analysis on the competition landscape in the global gastrointestinal stromal tumor market. Current market standings of emerging players and leading companies are disclosed in this section. This report also reveals the strategic developments of market participants to give insights on competitive business growth towards future market direction.

Market Taxonomy:

The report has segmented the global gastrointestinal stromal tumor market on the basis of regions, namely North America, Latin America, Europe, Asia-Pacific excluding Japan (APEJ), Japan, and Middle East and Africa. The report has provided country-specific forecast on the expansion of the overall gastrointestinal stromal tumor market. For extensive analysis, the global market for gastrointestinal stromal tumor is further segmented on the basis of indication, end-use and treatments.

On the basis of indication, the global gastrointestinal stromal tumor market is divided into:

  • Stomach
  • Small Intestine
  • Others

The key end-users in the global market for gastrointestinal stromal tumor include:

  • Hospitals
  • Clinics
  • Specialized Cancer Treatment Centers
  • Other End Users

Gastrointestinal stromal tumor treatments in the global market are:

  • Targeted Drug Therapy
  • Chemotherapy
  • Radiation Therapy
  • Surgery
  • Other Therapies

Research Methodology:

A team of analysts, research associates, and subject matter experts has developed this report by tracing the key elements instrumenting the growth in the gastrointestinal stromal tumor market. The report has aggregates the revenues that the market participants have procured through GIST treatments over the recent past. This data has been employed to generate baseline for market size forecasting. Metrics such as Year-on-Year growth rate, absolute dollar opportunities, and compounded annual growth rates, have been used to interpret the forecasted data. The overall market size estimations provided in the report are in US dollars (US$). The scope of the report is to deliver accurate forecast on the future of global gastrointestinal stromal tumor market and enable market participants towards taking informed decisions and developing new strategies for business growth. Companies can avail this report to change their presence in the global GIST market and increase their stake in it.

Table of Content

1. Global Economic Outlook

2. Global Gastrointestinal Stromal Tumor Market - Executive Summary

3. Global Gastrointestinal Stromal Tumor Market Overview

  • 3.1. Introduction
    • 3.1.1. Global Gastrointestinal Stromal Tumor Market Taxonomy
    • 3.1.2. Global Gastrointestinal Stromal Tumor Market Definition
  • 3.2. Global Gastrointestinal Stromal Tumor Market Size (US$ Mn) and Forecast, 2012-2026
    • 3.2.1. Global Gastrointestinal Stromal Tumor Market Y-o-Y Growth
  • 3.3. Global Gastrointestinal Stromal Tumor Market Dynamics
  • 3.4. Supply Chain
  • 3.5. Cost Structure
  • 3.6. Pricing Analysis
  • 3.7. Drug Pipeline Assessment
  • 3.8. PESTL Analysis
  • 3.9. List of Distributors
  • 3.10. Key Participant Market Presence (Intensity) Map

4. Global Gastrointestinal Stromal Tumor Market Analysis and Forecast 2012-2026

  • 4.1. Global Gastrointestinal Stromal Tumor Market Size and Forecast By Indication, 2012-2026
    • 4.1.1. Stomach Market Size and Forecast, 2012-2026
      • 4.1.1.1. Revenue (US$ Mn) Comparison, By Region
      • 4.1.1.2. Market Share Comparison, By Region
      • 4.1.1.3. Y-o-Y growth Comparison, By Region
    • 4.1.2. Small Intestine Market Size and Forecast, 2012-2026
      • 4.1.2.1. Revenue (US$ Mn) Comparison, By Region
      • 4.1.2.2. Market Share Comparison, By Region
      • 4.1.2.3. Y-o-Y growth Comparison, By Region
    • 4.1.3. Others Market Size and Forecast, 2012-2026
      • 4.1.3.1. Revenue (US$ Mn) Comparison, By Region
      • 4.1.3.2. Market Share Comparison, By Region
      • 4.1.3.3. Y-o-Y growth Comparison, By Region
  • 4.2. Global Gastrointestinal Stromal Tumor Market Size and Forecast By End User, 2012-2026
    • 4.2.1. Hospitals Market Size and Forecast, 2012-2026
      • 4.2.1.1. Revenue (US$ Mn) Comparison, By Region
      • 4.2.1.2. Market Share Comparison, By Region
      • 4.2.1.3. Y-o-Y growth Comparison, By Region
    • 4.2.2. Clinics Market Size and Forecast, 2012-2026
      • 4.2.2.1. Revenue (US$ Mn) Comparison, By Region
      • 4.2.2.2. Market Share Comparison, By Region
      • 4.2.2.3. Y-o-Y growth Comparison, By Region
    • 4.2.3. Specialized Cancer Treatment Centers Market Size and Forecast, 2012-2026
      • 4.2.3.1. Revenue (US$ Mn) Comparison, By Region
      • 4.2.3.2. Market Share Comparison, By Region
      • 4.2.3.3. Y-o-Y growth Comparison, By Region
    • 4.2.4. Other End Users Market Size and Forecast, 2012-2026
      • 4.2.4.1. Revenue (US$ Mn) Comparison, By Region
      • 4.2.4.2. Market Share Comparison, By Region
      • 4.2.4.3. Y-o-Y growth Comparison, By Region
  • 4.3. Global Gastrointestinal Stromal Tumor Market Size and Forecast By Treatment Type, 2012-2026
    • 4.3.1. Targeted Drug Therapy Market Size and Forecast, 2012-2026
      • 4.3.1.1. Revenue (US$ Mn) Comparison, By Region
      • 4.3.1.2. Market Share Comparison, By Region
      • 4.3.1.3. Y-o-Y growth Comparison, By Region
    • 4.3.2. Chemotherapy Market Size and Forecast, 2012-2026
      • 4.3.2.1. Revenue (US$ Mn) Comparison, By Region
      • 4.3.2.2. Market Share Comparison, By Region
      • 4.3.2.3. Y-o-Y growth Comparison, By Region
    • 4.3.3. Radiation Therapy Market Size and Forecast, 2012-2026
      • 4.3.3.1. Revenue (US$ Mn) Comparison, By Region
      • 4.3.3.2. Market Share Comparison, By Region
      • 4.3.3.3. Y-o-Y growth Comparison, By Region
    • 4.3.4. Surgery Market Size and Forecast, 2012-2026
      • 4.3.4.1. Revenue (US$ Mn) Comparison, By Region
      • 4.3.4.2. Market Share Comparison, By Region
      • 4.3.4.3. Y-o-Y growth Comparison, By Region
    • 4.3.5. Other Therapies Market Size and Forecast, 2012-2026
      • 4.3.5.1. Revenue (US$ Mn) Comparison, By Region
      • 4.3.5.2. Market Share Comparison, By Region
      • 4.3.5.3. Y-o-Y growth Comparison, By Region

5. North America Gastrointestinal Stromal Tumor Market Size and Forecast, 2012-2026

  • 5.1. North America Outlook
  • 5.2. North America Parent Market Outlook
  • 5.3. North America Target Market Outlook
  • 5.4. Revenue (US$ Mn) Comparison, By Country
    • 5.4.1. US Market Size and Forecast (US$ Mn), 2012-2026
    • 5.4.2. Canada Market Size and Forecast (US$ Mn), 2012-2026
  • 5.5. Revenue (US$ Mn) Comparison, By Indication
  • 5.6. Revenue (US$ Mn) Comparison, By End User
  • 5.7. Revenue (US$ Mn) Comparison, By Treatment Type

6. Latin America Gastrointestinal Stromal Tumor Market Size and Forecast, 2012-2026

  • 6.1. Latin America Outlook
  • 6.2. Latin America Parent Market Outlook
  • 6.3. Latin America Target Market Outlook
  • 6.4. Revenue (US$ Mn) Comparison, By Country
    • 6.4.1. Brazil Market Size and Forecast (US$ Mn), 2012-2026
    • 6.4.2. Mexico Market Size and Forecast (US$ Mn), 2012-2026
    • 6.4.3. Rest of Latin America Market Size and Forecast (US$ Mn), 2012-2026
  • 6.5. Revenue (US$ Mn) Comparison, By Indication
  • 6.6. Revenue (US$ Mn) Comparison, By End User
  • 6.7. Revenue (US$ Mn) Comparison, By Treatment Type

7. Europe Gastrointestinal Stromal Tumor Market Size and Forecast, 2012-2026

  • 7.1. Europe Outlook
  • 7.2. Europe Parent Market Outlook
  • 7.3. Europe Target Market Outlook
  • 7.4. Revenue (US$ Mn) Comparison, By Country
    • 7.4.1. Germany Market Size and Forecast (US$ Mn), 2012-2026
    • 7.4.2. UK Market Size and Forecast (US$ Mn), 2012-2026
    • 7.4.3. France Market Size and Forecast (US$ Mn), 2012-2026
    • 7.4.4. Spain Market Size and Forecast (US$ Mn), 2012-2026
    • 7.4.5. Italy Market Size and Forecast (US$ Mn), 2012-2026
    • 7.4.6. Rest of Europe Market Size and Forecast (US$ Mn), 2012-2026
  • 7.5. Revenue (US$ Mn) Comparison, By Indication
  • 7.6. Revenue (US$ Mn) Comparison, By End User
  • 7.7. Revenue (US$ Mn) Comparison, By Treatment Type

8. Japan Gastrointestinal Stromal Tumor Market Size and Forecast, 2012-2026

  • 8.1. Japan Outlook
  • 8.2. Japan Parent Market Outlook
  • 8.3. Japan Target Market Outlook
  • 8.4. Revenue (US$ Mn) Comparison, By Country
    • 8.4.1. Japan Market Size and Forecast (US$ Mn), 2012-2026
  • 8.5. Revenue (US$ Mn) Comparison, By Indication
  • 8.6. Revenue (US$ Mn) Comparison, By End User
  • 8.7. Revenue (US$ Mn) Comparison, By Treatment Type

9. APEJ Gastrointestinal Stromal Tumor Market Size and Forecast, 2012-2026

  • 9.1. APEJ Outlook
  • 9.2. APEJ Parent Market Outlook
  • 9.3. APEJ Target Market Outlook
  • 9.4. Revenue (US$ Mn) Comparison, By Country
    • 9.4.1. China Market Size and Forecast (US$ Mn), 2012-2026
    • 9.4.2. India Market Size and Forecast (US$ Mn), 2012-2026
    • 9.4.3. Thailand Market Size and Forecast (US$ Mn), 2012-2026
    • 9.4.4. Singapore Market Size and Forecast (US$ Mn), 2012-2026
    • 9.4.5. Australia Market Size and Forecast (US$ Mn), 2012-2026
    • 9.4.6. Rest of APEJ Market Size and Forecast (US$ Mn), 2012-2026
  • 9.5. Revenue (US$ Mn) Comparison, By Indication
  • 9.6. Revenue (US$ Mn) Comparison, By End User
  • 9.7. Revenue (US$ Mn) Comparison, By Treatment Type

10. MEA Gastrointestinal Stromal Tumor Market Size and Forecast, 2012-2026

  • 10.1. MEA Outlook
  • 10.2. MEA Parent Market Outlook
  • 10.3. MEA Target Market Outlook
  • 10.4. Revenue (US$ Mn) Comparison, By Country
    • 10.4.1. GCC Countries Market Size and Forecast (US$ Mn), 2012-2026
    • 10.4.2. South Africa Market Size and Forecast (US$ Mn), 2012-2026
    • 10.4.3. Nigeria Market Size and Forecast (US$ Mn), 2012-2026
    • 10.4.4. Rest of MEA Market Size and Forecast (US$ Mn), 2012-2026
  • 10.5. Revenue (US$ Mn) Comparison, By Indication
  • 10.6. Revenue (US$ Mn) Comparison, By End User
  • 10.7. Revenue (US$ Mn) Comparison, By Treatment Type

11. Global Gastrointestinal Stromal Tumor Market Company Share, Competition Landscape and Company Profiles

  • 11.1. Company Share Analysis
  • 11.2. Competition Landscape
  • 11.3. Company Profiles
    • 11.3.1. Novartis AG
    • 11.3.2. Sun Pharmaceutical Industries Limited
    • 11.3.3. Pfizer Inc.
    • 11.3.4. Bayer Aktiengesellschaft
    • 11.3.5. NATCO Pharma Limited

12. Research Methodology

13. Secondary and Primary Sources

14. Assumptions and Acronyms

15. Disclaimer

List of Table

  • TABLE 1: Global Gastrointestinal Stromal Tumor Market Value (US$ Mn), 2012-2017
  • TABLE 2: Global Gastrointestinal Stromal Tumor Market Value (US$ Mn), 2018-2026
  • TABLE 3: Global Gastrointestinal Stromal Tumor Market Value (US$ Mn) and Y-o-Y, 2017-2026
  • TABLE 4: Global Stomach Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 5: Global Stomach Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 6: Global Stomach Segment Market Share, By Region 2012-2017
  • TABLE 7: Global Stomach Segment Market Share, By Region 2018-2026
  • TABLE 8: Global Stomach Segment Y-o-Y, By Region 2017-2026
  • TABLE 9: Global Small Intestine Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 10: Global Small Intestine Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 11: Global Small Intestine Segment Market Share, By Region 2012-2017
  • TABLE 12: Global Small Intestine Segment Market Share, By Region 2018-2026
  • TABLE 13: Global Small Intestine Segment Y-o-Y, By Region 2017-2026
  • TABLE 14: Global Others Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 15: Global Others Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 16: Global Others Segment Market Share, By Region 2012-2017
  • TABLE 17: Global Others Segment Market Share, By Region 2018-2026
  • TABLE 18: Global Others Segment Y-o-Y, By Region 2017-2026
  • TABLE 19: Global Hospitals Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 20: Global Hospitals Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 21: Global Hospitals Segment Market Share, By Region 2012-2017
  • TABLE 22: Global Hospitals Segment Market Share, By Region 2018-2026
  • TABLE 23: Global Hospitals Segment Y-o-Y, By Region 2017-2026
  • TABLE 24: Global Clinics Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 25: Global Clinics Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 26: Global Clinics Segment Market Share, By Region 2012-2017
  • TABLE 27: Global Clinics Segment Market Share, By Region 2018-2026
  • TABLE 28: Global Clinics Segment Y-o-Y, By Region 2017-2026
  • TABLE 29: Global Specialized Cancer Treatment Centers Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 30: Global Specialized Cancer Treatment Centers Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 31: Global Specialized Cancer Treatment Centers Segment Market Share, By Region 2012-2017
  • TABLE 32: Global Specialized Cancer Treatment Centers Segment Market Share, By Region 2018-2026
  • TABLE 33: Global Specialized Cancer Treatment Centers Segment Y-o-Y, By Region 2017-2026
  • TABLE 34: Global Other End Users Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 35: Global Other End Users Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 36: Global Other End Users Segment Market Share, By Region 2012-2017
  • TABLE 37: Global Other End Users Segment Market Share, By Region 2018-2026
  • TABLE 38: Global Other End Users Segment Y-o-Y, By Region 2017-2026
  • TABLE 39: Global Targeted Drug Therapy Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 40: Global Targeted Drug Therapy Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 41: Global Targeted Drug Therapy Segment Market Share, By Region 2012-2017
  • TABLE 42: Global Targeted Drug Therapy Segment Market Share, By Region 2018-2026
  • TABLE 43: Global Targeted Drug Therapy Segment Y-o-Y, By Region 2017-2026
  • TABLE 44: Global Chemotherapy Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 45: Global Chemotherapy Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 46: Global Chemotherapy Segment Market Share, By Region 2012-2017
  • TABLE 47: Global Chemotherapy Segment Market Share, By Region 2018-2026
  • TABLE 48: Global Chemotherapy Segment Y-o-Y, By Region 2017-2026
  • TABLE 49: Global Radiation Therapy Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 50: Global Radiation Therapy Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 51: Global Radiation Therapy Segment Market Share, By Region 2012-2017
  • TABLE 52: Global Radiation Therapy Segment Market Share, By Region 2018-2026
  • TABLE 53: Global Radiation Therapy Segment Y-o-Y, By Region 2017-2026
  • TABLE 54: Global Surgery Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 55: Global Surgery Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 56: Global Surgery Segment Market Share, By Region 2012-2017
  • TABLE 57: Global Surgery Segment Market Share, By Region 2018-2026
  • TABLE 58: Global Surgery Segment Y-o-Y, By Region 2017-2026
  • TABLE 59: Global Other Therapies Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 60: Global Other Therapies Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 61: Global Other Therapies Segment Market Share, By Region 2012-2017
  • TABLE 62: Global Other Therapies Segment Market Share, By Region 2018-2026
  • TABLE 63: Global Other Therapies Segment Y-o-Y, By Region 2017-2026
  • TABLE 64: North America Current Expenditure on Health, (% of GDP), by Country, 2010 - 2016
  • TABLE 65: North America Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
  • TABLE 66: North America Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
  • TABLE 67: North America Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
  • TABLE 68: North America Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
  • TABLE 69: North America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2012-2017
  • TABLE 70: North America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2018-2026
  • TABLE 71: North America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2012-2017
  • TABLE 72: North America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2018-2026
  • TABLE 73: North America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2012-2017
  • TABLE 74: North America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2018-2026
  • TABLE 75: North America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2012-2017
  • TABLE 76: North America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2018-2026
  • TABLE 77: Latin America Current Expenditure on Health, (% of GDP), by Country, 2010 - 2016
  • TABLE 78: Latin America Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
  • TABLE 79: Latin America Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
  • TABLE 80: Latin America Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
  • TABLE 81: Latin America Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
  • TABLE 82: Latin America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2012-2017
  • TABLE 83: Latin America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2018-2026
  • TABLE 84: Latin America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2012-2017
  • TABLE 85: Latin America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2018-2026
  • TABLE 86: Latin America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2012-2017
  • TABLE 87: Latin America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2018-2026
  • TABLE 88: Latin America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2012-2017
  • TABLE 89: Latin America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2018-2026
  • TABLE 90: Europe Current Expenditure on Health, (% of GDP), by Country, 2010 - 2016
  • TABLE 91: Europe Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
  • TABLE 92: Europe Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
  • TABLE 93: Europe Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
  • TABLE 94: Europe Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
  • TABLE 95: Europe Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2012-2017
  • TABLE 96: Europe Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2018-2026
  • TABLE 97: Europe Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2012-2017
  • TABLE 98: Europe Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2018-2026
  • TABLE 99: Europe Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2012-2017
  • TABLE 100: Europe Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2018-2026
  • TABLE 101: Europe Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2012-2017
  • TABLE 102: Europe Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2018-2026
  • TABLE 103: Japan Current Expenditure on Health, (% of GDP), by Country, 2010 - 2016
  • TABLE 104: Japan Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
  • TABLE 105: Japan Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
  • TABLE 106: Japan Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
  • TABLE 107: Japan Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
  • TABLE 108: Japan Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2012-2017
  • TABLE 109: Japan Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2018-2026
  • TABLE 110: Japan Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2012-2017
  • TABLE 111: Japan Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2018-2026
  • TABLE 112: Japan Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2012-2017
  • TABLE 113: Japan Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2018-2026
  • TABLE 114: Japan Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2012-2017
  • TABLE 115: Japan Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2018-2026
  • TABLE 116: APEJ Current Expenditure on Health, (% of GDP), by Country, 2010 - 2016
  • TABLE 117: APEJ Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
  • TABLE 118: APEJ Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
  • TABLE 119: APEJ Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
  • TABLE 120: APEJ Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
  • TABLE 121: APEJ Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2012-2017
  • TABLE 122: APEJ Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2018-2026
  • TABLE 123: APEJ Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2012-2017
  • TABLE 124: APEJ Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2018-2026
  • TABLE 125: APEJ Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2012-2017
  • TABLE 126: APEJ Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2018-2026
  • TABLE 127: APEJ Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2012-2017
  • TABLE 128: APEJ Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2018-2026
  • TABLE 129: MEA Current Expenditure on Health, (% of GDP), by Country, 2010 - 2016
  • TABLE 130: MEA Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
  • TABLE 131: MEA Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
  • TABLE 132: MEA Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
  • TABLE 133: MEA Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
  • TABLE 134: MEA Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2012-2017
  • TABLE 135: MEA Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2018-2026
  • TABLE 136: MEA Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2012-2017
  • TABLE 137: MEA Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2018-2026
  • TABLE 138: MEA Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2012-2017
  • TABLE 139: MEA Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2018-2026
  • TABLE 140: MEA Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2012-2017
  • TABLE 141: MEA Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2018-2026

List of Figures

  • FIG. 1: Global Gastrointestinal Stromal Tumor Market Value (US$ Mn), 2012-2017
  • FIG. 2: Global Gastrointestinal Stromal Tumor Market Value (US$ Mn) Forecast, 2018-2026
  • FIG. 3: Global Gastrointestinal Stromal Tumor Market Value (US$ Mn) and Y-o-Y, 2017-2026
  • FIG. 4: Global Stomach Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 5: Global Stomach Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 6: Global Stomach Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 7: Global Small Intestine Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 8: Global Small Intestine Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 9: Global Small Intestine Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 10: Global Others Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 11: Global Others Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 12: Global Others Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 13: Global Hospitals Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 14: Global Hospitals Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 15: Global Hospitals Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 16: Global Clinics Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 17: Global Clinics Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 18: Global Clinics Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 19: Global Specialized Cancer Treatment Centers Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 20: Global Specialized Cancer Treatment Centers Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 21: Global Specialized Cancer Treatment Centers Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 22: Global Other End Users Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 23: Global Other End Users Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 24: Global Other End Users Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 25: Global Targeted Drug Therapy Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 26: Global Targeted Drug Therapy Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 27: Global Targeted Drug Therapy Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 28: Global Chemotherapy Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 29: Global Chemotherapy Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 30: Global Chemotherapy Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 31: Global Radiation Therapy Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 32: Global Radiation Therapy Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 33: Global Radiation Therapy Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 34: Global Surgery Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 35: Global Surgery Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 36: Global Surgery Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 37: Global Other Therapies Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 38: Global Other Therapies Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 39: Global Other Therapies Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 40: North America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2012-2017
  • FIG. 41: North America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2018-2026
  • FIG. 42: North America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2012-2017
  • FIG. 43: North America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2018-2026
  • FIG. 44: North America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2012-2017
  • FIG. 45: North America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2018-2026
  • FIG. 46: North America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2012-2017
  • FIG. 47: North America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2018-2026
  • FIG. 48: Latin America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2012-2017
  • FIG. 49: Latin America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2018-2026
  • FIG. 50: Latin America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2012-2017
  • FIG. 51: Latin America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2018-2026
  • FIG. 52: Latin America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2012-2017
  • FIG. 53: Latin America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2018-2026
  • FIG. 54: Latin America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2012-2017
  • FIG. 55: Latin America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2018-2026
  • FIG. 56: Europe Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2012-2017
  • FIG. 57: Europe Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2018-2026
  • FIG. 58: Europe Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2012-2017
  • FIG. 59: Europe Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2018-2026
  • FIG. 60: Europe Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2012-2017
  • FIG. 61: Europe Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2018-2026
  • FIG. 62: Europe Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2012-2017
  • FIG. 63: Europe Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2018-2026
  • FIG. 64: Japan Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2012-2017
  • FIG. 65: Japan Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2018-2026
  • FIG. 66: Japan Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2012-2017
  • FIG. 67: Japan Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2018-2026
  • FIG. 68: Japan Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2012-2017
  • FIG. 69: Japan Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2018-2026
  • FIG. 70: Japan Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2012-2017
  • FIG. 71: Japan Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2018-2026
  • FIG. 72: APEJ Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2012-2017
  • FIG. 73: APEJ Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2018-2026
  • FIG. 74: APEJ Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2012-2017
  • FIG. 75: APEJ Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2018-2026
  • FIG. 76: APEJ Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2012-2017
  • FIG. 77: APEJ Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2018-2026
  • FIG. 78: APEJ Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2012-2017
  • FIG. 79: APEJ Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2018-2026
  • FIG. 80: MEA Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2012-2017
  • FIG. 81: MEA Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2018-2026
  • FIG. 82: MEA Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2012-2017
  • FIG. 83: MEA Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2018-2026
  • FIG. 84: MEA Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2012-2017
  • FIG. 85: MEA Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2018-2026
  • FIG. 86: MEA Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2012-2017
  • FIG. 87: MEA Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2018-2026
Back to Top